Locally advanced pancreatic cancer. Looking beyond traditional chemotherapy and radiation: Highlights from the "2013 ASCO Annual Meeting". Chicago, IL, USA; May 30 - June 4, 2013

Journal of the Pancreas

Volumn 14, Issue 4, 2013, Pages 337-339

  Savir, Guy ^a   Huber, Kathryn E ^a   Wasif Saif, Muhammad ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Chemoradiation; Immunotherapy; Neoadjuvant therapy

Indexed keywords

CAPECITABINE; ERLOTINIB; FLUOROURACIL; GEMCITABINE; MITOMYCIN; TERTOMOTIDE;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONSENSUS DEVELOPMENT; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MEDICAL EDUCATION; MEDICAL SOCIETY; ONCOLOGY; OVERALL SURVIVAL; PALLIATIVE THERAPY; PANCREAS CANCER; PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT DURATION; TREATMENT PLANNING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS, PHASE III AS TOPIC; DEOXYCYTIDINE; FLUOROURACIL; HUMANS; PANCREATIC NEOPLASMS; PEPTIDE FRAGMENTS; QUINAZOLINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL ANALYSIS; TELOMERASE; TREATMENT OUTCOME; VACCINES;

EID: 84880058771     PISSN: 15908577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Hidalgo M. Pancreatic cancer. N Eng J Med 2010; 362:1605-17.
2. Iacobuzio-Donahue CA, Fu B, Yachida S et al. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol 2009; 27: 1806-1813.
3. Moertel CG. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer. 1981 Oct 15;48(8):1705-10.
4. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group. J Natl Cancer Inst 1988;80(10):751-755.
5. Cohen SJ, et al. A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-c in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282. Int J Radiat Oncol Biol Phys 2005;62(5): 1345-1350.
6. Klassen DJ, et al. Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil-an Eastern Cooperative Oncology Group study. J Clin Oncol 1985;3(3):373-378.
7. Burris HA III, Moore MJ, Anderson J, et al: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial. J Clin Oncol 15:2403-2413, 1997.
8. Chauffert B, et al. Phase III trial comparing intensive induction chemoradiotherapy (60Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study. Ann Oncol 2008;19(9):1592-1599.
9. Loehrer PJ. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. J Clin Oncol. 2011 Nov 1;29(31):4105-12.
10. Li CP, et al. Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study. Int J Radiat Oncol Biol Phys 2003;57(1):98-104.
11. Mukherjee S. Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial. Lancet Oncol. 2013 Apr;14(4):317-26.
12. Hammel, et al. Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study. J Clin Oncol 31,2013 (suppl; abstr #LBA4003)
13. Middleton G W, et al. A phase III randomized trial of chemoimmunotherapy comprising gemcitabine and capecitabine with or without telomerase vaccine GV 1001 in patients with locally advanced or metastatic pancreatic cancer. J Clin Oncol 31, 2013 (suppl; abstr #LBA4004).